These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 9197356)
21. Absence of irreversible rejection in the presence of warm anti-donor-HLA class I cytotoxic IgG antibody. Shoker A; Klassen J; Herbut B Clin Nephrol; 1997 Feb; 47(2):87-91. PubMed ID: 9049455 [TBL] [Abstract][Full Text] [Related]
22. Postoperative flow cytometry crossmatch in living donor liver transplantation: clinical significance of humoral immunity in acute rejection. Kasahara M; Kiuchi T; Takakura K; Uryuhara K; Egawa H; Asonuma K; Uemoto S; Inomata Y; Ohwada S; Morishita Y; Tanaka K Transplantation; 1999 Feb; 67(4):568-75. PubMed ID: 10071029 [TBL] [Abstract][Full Text] [Related]
23. Specificity and Ig class of preformed alloantibodies causing a positive crossmatch in renal transplantation. The implications for graft survival. ten Hoor GM; Coopmans M; Allebes WA Transplantation; 1993 Aug; 56(2):298-304. PubMed ID: 7689256 [TBL] [Abstract][Full Text] [Related]
24. HLA-DR matched transfusions: development of donor-specific T- and B-cell antibodies and renal allograft outcome. Christiaans MH; van Hooff JP; Nieman F; van den Berg-Loonen EM Transplantation; 1999 Apr; 67(7):1029-35. PubMed ID: 10221489 [TBL] [Abstract][Full Text] [Related]
25. Preferential benefit of antibody induction therapy in kidney recipients with high pretransplant frequencies of donor-reactive interferon-gamma enzyme-linked immunosorbent spots. Augustine JJ; Poggio ED; Heeger PS; Hricik DE Transplantation; 2008 Aug; 86(4):529-34. PubMed ID: 18724221 [TBL] [Abstract][Full Text] [Related]
26. Current experience with renal transplantation across the ABO barrier. Nelson PW; Helling TS; Shield CF; Beck M; Bryan CF Am J Surg; 1992 Nov; 164(5):541-4; discussion 544-5. PubMed ID: 1443385 [TBL] [Abstract][Full Text] [Related]
27. Cytotoxic flow cytometric crossmatch in renal transplantation: a single assay to simultaneously detect antibody binding and cytotoxicity. Thammanichanond D; Athimang W; Paisooksantivatana K; Mongkolsuk T; Ingsathit A; Worawichawong S; Kitpoka P; Jirasiritham S; Kantachuvesiri S Transplant Proc; 2012 Jan; 44(1):62-5. PubMed ID: 22310580 [TBL] [Abstract][Full Text] [Related]
29. Biomarkers in transplantation: Prospective, blinded measurement of predictive value for the flow cytometry crossmatch after negative antiglobulin crossmatch in kidney transplantation. Wen R; Wu V; Dmitrienko S; Yu A; Balshaw R; Keown PA; Kidney Int; 2006 Oct; 70(8):1474-81. PubMed ID: 16941026 [TBL] [Abstract][Full Text] [Related]
30. Donor-specific antibodies after transplantation by flow cytometry: relative change in fluorescence ratio most sensitive risk factor for graft survival. Christiaans MH; Overhof-de Roos R; Nieman F; van Hooff JP; van den Berg-Loonen EM Transplantation; 1998 Feb; 65(3):427-33. PubMed ID: 9484765 [TBL] [Abstract][Full Text] [Related]
31. [ABO incompatible living donor kidney transplantation: a dream come true. Experience of Hospital Clínic of Barcelona]. Oppenheimer F; Revuelta I; Serra N; Lozano M; Gutiérrez-Dalmau A; Esforzado N; Cofán F; Ricart MJ; Torregrosa JV; Crespo M; Paredes D; Martorell J; Alcáraz A; Campistol JM Nefrologia; 2010; 30(1):54-63. PubMed ID: 20038970 [TBL] [Abstract][Full Text] [Related]
33. Flow cytometric detection of HLA-specific antibodies as a predictor of heart allograft rejection. Tambur AR; Bray RA; Takemoto SK; Mancini M; Costanzo MR; Kobashigawa JA; D'Amico CL; Kanter KR; Berg A; Vega JD; Smith AL; Roggero AL; Ortegel JW; Wilmoth-Hosey L; Cecka JM; Gebel HM Transplantation; 2000 Oct; 70(7):1055-9. PubMed ID: 11045642 [TBL] [Abstract][Full Text] [Related]
34. Donor-specific IgG antibody and the chronic rejection of human renal allografts. Pierce JC; Kay S; Lee HM Surgery; 1975 Jul; 78(1):14-21. PubMed ID: 1094575 [TBL] [Abstract][Full Text] [Related]